NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)

CUSIP: 65343E108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
3,602,511
Total 13F shares
14,456,827
Share change
+1,223,180
Total reported value
$67,938,572
Put/Call ratio
34%
Price per share
$4.70
Number of holders
49
Value change
+$5,637,581
Number of buys
19
Number of sells
26

Security key

65343E108

Report period

Q2 2022

Institutions

49

Top holders

10

Top shareholders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
13F
Company
75%
2,711,013
$13,176,000 31 Mar 2022
13F
Sofinnova Investments, Inc.
13F
Company
74%
2,671,856
$12,985,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
35%
1,266,114
$6,154,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
28%
1,013,305
$4,925,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
19%
689,781
$3,353,000 31 Mar 2022
13F
FEDERATED HERMES, INC.
13F
Company
15%
525,572
$2,554,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
11%
389,989
$1,896,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
10%
373,086
$1,813,000 31 Mar 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
9.8%
353,253
$1,717,000 31 Mar 2022
13F
Long Focus Capital Management, LLC
13F
Company
9.7%
350,000
$1,701,000 31 Mar 2022
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
9.3%
334,384
$1,623,000 31 Mar 2022
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
5.4%
196,187
$953,000 31 Mar 2022
13F
DAFNA Capital Management LLC
13F
Company
5.2%
187,696
$912,000 31 Mar 2022
13F
Woodline Partners LP
13F
Company
4.5%
161,638
$786,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4.2%
151,811
$737,000 31 Mar 2022
13F
MACQUARIE GROUP LTD
13F
Company
4.2%
150,000
$729,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.1%
148,800
$723,000 31 Mar 2022
13F
Ikarian Capital, LLC
13F
Company
3.9%
141,058
$686,000 31 Mar 2022
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
3.7%
134,700
$655,000 31 Mar 2022
13F
Sio Capital Management, LLC
13F
Company
3.6%
130,000
$632,000 31 Mar 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
3.1%
111,012
$540,000 31 Mar 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
2.9%
103,500
$503,000 31 Mar 2022
13F
ExodusPoint Capital Management, LP
13F
Company
2.6%
93,406
$454,000 31 Mar 2022
13F
BARCLAYS PLC
13F
Company
2%
72,886
$354,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
2%
70,432
$342,000 31 Mar 2022
13F
Atom Investors LP
13F
Company
1.8%
63,866
$310,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
1.6%
57,092
$277,000 31 Mar 2022
13F
NOMURA HOLDINGS INC
13F
Company
1.4%
51,910
$258,000 31 Mar 2022
13F
NORGES BANK
13F
Company
1.4%
51,900
$252,234 31 Mar 2022
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
1.3%
47,650
$232,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
1.2%
42,742
$208,000 31 Mar 2022
13F
Trexquant Investment LP
13F
Company
1%
36,981
$180,000 31 Mar 2022
13F
Veritable, L.P.
13F
Company
1%
36,807
$179,000 31 Mar 2022
13F
FRANKLIN RESOURCES INC
13F
Company
1%
35,900
$174,000 31 Mar 2022
13F
Minerva Advisors LLC
13F
Company
0.88%
31,713
$154,000 31 Mar 2022
13F
BAILARD, INC.
13F
Company
0.85%
30,600
$149,000 31 Mar 2022
13F
Krensavage Asset Management, LLC
13F
Company
0.85%
30,591
$149,000 31 Mar 2022
13F
Squarepoint Ops LLC
13F
Company
0.56%
20,266
$98,000 31 Mar 2022
13F
HSBC HOLDINGS PLC
13F
Company
0.51%
18,397
$91,000 31 Mar 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.51%
18,465
$90,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.5%
17,895
$87,000 31 Mar 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.48%
17,348
$85,000 31 Mar 2022
13F
ALGERT GLOBAL LLC
13F
Company
0.44%
15,982
$78,000 31 Mar 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.42%
15,054
$73,000 31 Mar 2022
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.37%
13,470
$65,000 31 Mar 2022
13F
Corton Capital Inc.
13F
Company
0.35%
12,662
$62,000 31 Mar 2022
13F
HARBOURVEST PARTNERS LLC
13F
Company
0.28%
10,044
$49,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.28%
10,000
$49,000 31 Mar 2022
13F
UBS Group AG
13F
Company
0.25%
9,160
$45,000 31 Mar 2022
13F
Quantbot Technologies LP
13F
Company
0.06%
2,100
$10,000 31 Mar 2022
13F

Institutional Holders of NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) as of Q2 2022

As of 30 Jun 2022, NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,456,827 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., BlackRock Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, K2 PRINCIPAL FUND, L.P., Long Focus Capital Management, LLC, FEDERATED HERMES, INC., DIMENSIONAL FUND ADVISORS LP, and CITADEL ADVISORS LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
57
Q2 2022 holders
49
Holder diff
-8
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .